The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Nerve Tonic
calcium phosphate, iron, potassium phosphate, unspecified form, magnesium phosphate, dibasic trihydrate, and sodium phosphate · CALCIUM PHOSPHATE, UNSPECIFIED FORM 3 [hp_X]/1; IRON 3 [hp_X]/1; POTASSIUM PHOSPHATE, UNSPECIFIED FORM 3 [hp_X]/1; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 3 [hp_X]/1; SODIUM PHOSPHATE 3 [hp_X]/1 · Tablet · Oral · Hyland's Inc.
NDC 54973-3014-02 · 1 BOTTLE, PLASTIC in 1 CARTON / 100 TABLET in 1 BOTTLE, PLASTIC · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Xywav and Xyrem
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of calcium phosphate, iron, potassium phosphate, unspecified form, magnesium phosphate, dibasic trihydrate, and sodium phosphate (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Hyland's Inc. | CALCIUM PHOSPHATE 3 [hp_X]/1; IRON 3 [hp_X]/1; POTASSIUM PHOSPHATE, UNSPECIFIED FORM 3 [hp_X]/1; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 3 [hp_X]/1; SODIUM PHOSPHATE 3 [hp_X]/1 | Jul 22, 2026 | Sep 2, 2026 |
| Hyland's Inc. | CALCIUM PHOSPHATE, UNSPECIFIED FORM 3 [hp_X]/1; IRON 3 [hp_X]/1; POTASSIUM PHOSPHATE, UNSPECIFIED FORM 3 [hp_X]/1; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 3 [hp_X]/1; SODIUM PHOSPHATE 3 [hp_X]/1 | Jul 22, 2026 | Sep 2, 2026 |
| Hyland's Inc. | CALCIUM PHOSPHATE 3 [hp_X]/1; IRON 3 [hp_X]/1; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 3 [hp_X]/1; POTASSIUM PHOSPHATE, UNSPECIFIED FORM 3 [hp_X]/1; SODIUM PHOSPHATE 3 [hp_X]/1 | Jul 15, 2026 | Jul 15, 2026 |
| Hyland's Inc. | CALCIUM PHOSPHATE, UNSPECIFIED FORM 3 [hp_X]/1; IRON 3 [hp_X]/1; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 3 [hp_X]/1; POTASSIUM PHOSPHATE, UNSPECIFIED FORM 3 [hp_X]/1; SODIUM PHOSPHATE 3 [hp_X]/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Nerve Tonic — NDC 54973-3014-02," retrieved September 3, 2026, https://drugdashboards.com/drug/54973301402.
Free to cite with attribution — see how the data is put together.